Pfizer Inc. and Moderna, Inc. are working with the US Food and Drug Administration and the Trump Administration’s Operation Warp Speed on when they should allow placebo recipients in their COVID-19 vaccine trials to cross over to the active vaccine, Operation Warp Speed chief science officer Moncef Slaoui said during a press briefing on 18 November.
Pfizer announced completed results from its late stage vaccine trial the same day, and Slaoui noted that Moderna may make...







